The impact of executive board gender diversity, R&D investment, marketing expenses on company performance in the healthcare industry

Anthony S.C. Tsui; Bernard Lee; Oliver H.M. Yau

doi:10.1080/15475778.2022.2051397

The impact of executive board gender diversity, R&D investment, marketing expenses on company performance in the healthcare industry

Anthony S.C. Tsui, Bernard Lee, Oliver H.M. Yau

Hong Kong Metropolitan University

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

There has been an increasing devotion to the gender balance on executive boards in China. There has been an assumption that increasing the proportion of women in the highest jobs will improve company performance and corporate governance. This research paper tests this assumption by studying a sample of 305 publicly listed healthcare companies in China in the period 2016–2019. We find that the choice of gender for board chair and CEO has a more impact on company performance than merely increasing the proportion of women on boards. Assessing the impact on company performance of different gender composition of board chairs and CEOs, we use an innovative approach to measure the relationship, using a proxy measurement in R&D, sales, and marketing expenses.

Original language	English
Pages (from-to)	3-36
Number of pages	34
Journal	Journal of Transnational Management
Volume	27
Issue number	1
DOIs	https://doi.org/10.1080/15475778.2022.2051397
Publication status	Published - 2022

Keywords

CEO
Gender
R&D investment
board chair
marketing expenses
sales performance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/15475778.2022.2051397

Cite this

@article{495432a8b25649c39d83268365c8685e,

title = "The impact of executive board gender diversity, R&D investment, marketing expenses on company performance in the healthcare industry",

abstract = "There has been an increasing devotion to the gender balance on executive boards in China. There has been an assumption that increasing the proportion of women in the highest jobs will improve company performance and corporate governance. This research paper tests this assumption by studying a sample of 305 publicly listed healthcare companies in China in the period 2016–2019. We find that the choice of gender for board chair and CEO has a more impact on company performance than merely increasing the proportion of women on boards. Assessing the impact on company performance of different gender composition of board chairs and CEOs, we use an innovative approach to measure the relationship, using a proxy measurement in R&D, sales, and marketing expenses.",

keywords = "CEO, Gender, R&D investment, board chair, marketing expenses, sales performance",

author = "Tsui, {Anthony S.C.} and Bernard Lee and Yau, {Oliver H.M.}",

note = "Funding Information: The authors thank the anonymous editor who provided insightful guidance in developing and refining this article. Publisher Copyright: {\textcopyright} 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.",

year = "2022",

doi = "10.1080/15475778.2022.2051397",

language = "English",

volume = "27",

pages = "3--36",

journal = "Journal of Transnational Management",

issn = "1547-5778",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - The impact of executive board gender diversity, R&D investment, marketing expenses on company performance in the healthcare industry

AU - Tsui, Anthony S.C.

AU - Lee, Bernard

AU - Yau, Oliver H.M.

N1 - Funding Information: The authors thank the anonymous editor who provided insightful guidance in developing and refining this article. Publisher Copyright: © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

PY - 2022

Y1 - 2022

N2 - There has been an increasing devotion to the gender balance on executive boards in China. There has been an assumption that increasing the proportion of women in the highest jobs will improve company performance and corporate governance. This research paper tests this assumption by studying a sample of 305 publicly listed healthcare companies in China in the period 2016–2019. We find that the choice of gender for board chair and CEO has a more impact on company performance than merely increasing the proportion of women on boards. Assessing the impact on company performance of different gender composition of board chairs and CEOs, we use an innovative approach to measure the relationship, using a proxy measurement in R&D, sales, and marketing expenses.

AB - There has been an increasing devotion to the gender balance on executive boards in China. There has been an assumption that increasing the proportion of women in the highest jobs will improve company performance and corporate governance. This research paper tests this assumption by studying a sample of 305 publicly listed healthcare companies in China in the period 2016–2019. We find that the choice of gender for board chair and CEO has a more impact on company performance than merely increasing the proportion of women on boards. Assessing the impact on company performance of different gender composition of board chairs and CEOs, we use an innovative approach to measure the relationship, using a proxy measurement in R&D, sales, and marketing expenses.

KW - CEO

KW - Gender

KW - R&D investment

KW - board chair

KW - marketing expenses

KW - sales performance

UR - http://www.scopus.com/inward/record.url?scp=85130223949&partnerID=8YFLogxK

U2 - 10.1080/15475778.2022.2051397

DO - 10.1080/15475778.2022.2051397

M3 - Article

AN - SCOPUS:85130223949

SN - 1547-5778

VL - 27

SP - 3

EP - 36

JO - Journal of Transnational Management

JF - Journal of Transnational Management

IS - 1

ER -

The impact of executive board gender diversity, R&D investment, marketing expenses on company performance in the healthcare industry

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this